Leadership Change

As Impact Capital Managers brings in heavy-hitters to its board, it’s a clear sign the $80B sector is moving from niche to mainstream. Here’s why.

American Rare Earths' new hire isn't just a board appointment; it's a strategic play to de-risk a massive U.S. deposit and court Wall Street capital.

With a new president and a $1B war chest, The Calida Group is reshaping the rental landscape. But what does this flood of capital mean for our cities?

United Roosevelt Savings Bank's triple hire isn't just a staff update; it's a calculated move to tackle risk, expand lending, and win the retail battle.

The global economist and author brings a unique, multi-sector perspective to the prestigious forum, aiming to tackle AI, geopolitics, and the energy transition.

Houston-based Bridgeway Capital Management’s latest strategic hires reveal a powerful trend: top finance professionals are seeking more than just returns.

PCS Retirement's new COO isn't just a leadership shuffle. It's a strategic move to manage explosive growth and overhaul its tech for advisors and savers.

By appointing Derek Kan, a public sector veteran and AI exec, Fortinet isn't just filling a seat. It's building a playbook for the AI era's biggest challenges.

Comp AI's new Head of Partnerships signals a strategic shift, framing security not as a cost but as core growth infrastructure. A deep dive into the business case.

Humanity Labs hires a top strategist to deploy its 'AI Workforce,' aiming to solve wealth management's capacity crisis by augmenting, not replacing, advisors.

A new board appointment reveals Serve Robotics' grand plan: to evolve from a delivery bot company into a foundational robotics infrastructure provider.

Bionano Genomics brings back OGM pioneer Dr. Alex Hastie as CSO. It's a strategic move to accelerate clinical adoption and restore investor confidence.

Incoming Nuwellis CEO Mike McCormick lays out a bold growth plan targeting critically ill children, but a closer look reveals a precarious financial balancing act.

Ashwin Rangan’s move to ReadyAI isn't just a new job. It’s a sign that for corporations, the chaotic era of AI experimentation is over and the age of governance has begun.

With a seasoned med-tech innovator at the helm, Picard Medical's SynCardia faces a pivotal moment. Can it expand its life-saving artificial heart monopoly?

With a Wall Street veteran as CFO and a top cardiologist as advisor, Australian AI firm Echo IQ is executing a calculated assault on the U.S. healthcare market.

A major investment from New Mountain Capital positions RRC Companies to scale its critical engineering services for the rapidly expanding green energy sector.

Behind a standard executive announcement lies a strategic play. Genesis is bringing in a proven growth leader to navigate the competitive U.S. luxury market.

In a strategic move, CERTIFY Health appoints Dan Romary as COO. His deep experience inside a top DSO signals a new era for tackling healthcare's fragmentation.